Compare ERAS & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERAS | SAH |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | 2021 | 1997 |
| Metric | ERAS | SAH |
|---|---|---|
| Price | $18.10 | $79.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $14.25 | ★ $78.25 |
| AVG Volume (30 Days) | ★ 3.1M | 284.4K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.07% |
| EPS Growth | ★ 36.23 | N/A |
| EPS | N/A | ★ 3.58 |
| Revenue | N/A | ★ $9,951,630,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | N/A | $4.16 |
| P/E Ratio | ★ N/A | $21.59 |
| Revenue Growth | N/A | ★ 0.86 |
| 52 Week Low | $1.33 | $54.11 |
| 52 Week High | $24.28 | $113.67 |
| Indicator | ERAS | SAH |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 39.08 |
| Support Level | $17.36 | $78.88 |
| Resistance Level | $18.20 | $84.61 |
| Average True Range (ATR) | 0.97 | 3.90 |
| MACD | -0.15 | -1.37 |
| Stochastic Oscillator | 34.58 | 11.23 |
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 107 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores in 10 states, 16 collision centers, and 20 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 56% of new-vehicle revenue. BMW is the largest brand at about 23%. 2025 revenue was $15.2 billion, with Texas and California constituting 51% of the total. EchoPark's portion was $2.1 billion.